Figures
Abstract
The air-blood barrier protects the lung from blood/serum entering the air spaces, i.e., from “drowning in your own fluids”. Failure leads to pulmonary edema, a regularly fatal complication during the Covid-19 pandemic which claimed 7 million lives worldwide. Finding no mathematical models for the underlying fluid mechanics, we created the first. Governing flow equations for alveolar capillary, interstitium, and alveolus are coupled by crossflows at the capillary and epithelial membranes and end-exit flows to the lymphatics. Case examples include normal/recovery, cardiogenic pulmonary edema, acute respiratory distress syndrome, effects of positive end expiratory pressure, and a wide range of parameter values for permeability of the membranes and interstitial matrix. Previously unknown membrane fluid shear stresses calculate to values that affect cell function in many systems. We add active epithelial reabsorption which has two effects: shifting streamlines to favor alveolar-lymphatic clearance and adding to the direct alveolar-capillary clearance. Simple algebraic equations are derived for the interstitial fluid pressure, pi, membrane crossflow velocities and the critical capillary pressure, pcrit, above which edema occurs. For validation, the pcrit predictions fit clinical definitions and flow calculations of lymphatic vs capillary clearance match animal experimental data. For decades the value of pi has been imposed as an input, whereas we calculate the value as an output. They don’t agree. Since the space is too small for measurements, the ability to calculate pi and pcrit offers new insights, questions long-held beliefs, and opens applications from physiological studies to personalized clinical care.
Author summary
Our fluid mechanics model of the air-blood barrier provides a new conceptual framework for developing and clearing pulmonary edema. It can be used to organize data, motivate experimental investigations, interpret cause-effect relationships, understand the physical basis of disease, suggest therapies, follow interventions, and personalize care. Parameter values for the anatomy and physiology of the alveolar-capillary-interstitial layers are incorporated into fluid physics equations. We predict the alveolar interstitial pressure, which can’t be measured, uncovering several misunderstandings in pulmonary physiology and medicine. Validation is achieved by deriving an equation for the critical alveolar capillary blood pressure leading to edema and calculations of alveolar edema clearance flow rate both directly to the capillary and to the lymphatic route. Both agree with clinical and experimental measurements. The flow mechanism to lymphatics resolves a puzzle, since 1896, as to how alveolar lymphatics function from so far away, and explains the paucity of lymphatics since direct clearance to the capillary is the major route by far.
Citation: Grotberg JB, Romanò F, Grotberg JC (2025) Flow mechanisms of the air-blood barrier. PLoS Comput Biol 21(4): e1012917. https://doi.org/10.1371/journal.pcbi.1012917
Editor: Jason A. Papin, University of Virginia, UNITED STATES OF AMERICA
Received: October 7, 2024; Accepted: February 25, 2025; Published: April 10, 2025
Copyright: © 2025 Grotberg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are in the manuscript and its supporting information files.
Funding: JCG was supported by NIH grant T32 HL007317. JBG and FR were supported by NIH Grant RO1 HL136141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Pulmonary edema is broadly defined as an abnormal accumulation of fluid in lung interstitium and alveoli, and may be categorized as cardiogenic pulmonary edema (CPE) or non-cardiogenic in origin. The former is classically seen in congestive heart failure, where elevated lung capillary blood pressure drives fluid across the air-blood barrier. Approximately 1 million people in the US suffer from this condition annually [1]. Acute CPE has an in-hospital mortality rate of 30–40% [2]. The latter involves damage to that barrier leading, in severe cases, to acute respiratory distress syndrome (ARDS) [3,4]. Prior to the COVID-19 pandemic approximately 190,000 patients were diagnosed with ARDS annually in the US [5] at ~40% mortality [6]. Those numbers skyrocketed in the US, and around the world with the pandemic involving particular features related to the infection [7]. They include the acute onset of bilateral alveolar opacities, reduced lung compliance with high shunt fraction, and the classic histopathology of diffuse alveolar damage (DAD) and pulmonary vascular endothelialitis [8,9]. Pulmonary arterial catheters (PACs) used to measure pulmonary capillary wedge pressure (PCWP) ≤ 18 mmHg [10] supports the diagnosis of non-CPE.
While the focus on pulmonary edema has grown, the field has long lacked a robust mechanistic model, particularly as it pertains to alveolar microvascular fluid dynamics. Such models can be used to structure physiological studies, interpret data, sort diagnoses, promote personalization of interventions, and monitor therapeutic responses. With the experience of a worldwide COVID-19 pandemic costing nearly 7 million lives, there is compelling motivation to establish and investigate a detailed fluid mechanical model of pulmonary edema based on fundamental physics. This is quite unlike the history of fluid mechanics models for arterial blood flow, which date back to the mid-19th century. As a starting point, we recently published a model [11] as an initial step, and here add important new, clinically significant features. First, we upgrade from the Darcy porous media model to the Brinkman model. This allows us to calculate fluid flow shear stresses, especially the wall shear applied to the interstitial side of both the alveolar epithelium and the capillary endothelium. Cells are known to be biologically responsive to their shear environment. Second, we account for active fluid reabsorption that is known to occur at the alveolar epithelium. It is accomplished by imposing a constant absorption fluid velocity, vab, there. Both of these new features allow further investigations, validations, and applications.
Fig 1a (A) shows the gross lung anatomy in the chest including the left and right lung and parts of the airway tree (trachea, large airways) while (B) is a small-scale view including the capillary network, alveolar liquid with surfactant, and the interstitium [12]. In a sketch of the pulmonary lobular anatomy in cross section [13], the alveoli are on the order of in diameter and the interalveolar septa are
thick [14,15]. The capillary network runs within the septa and passes by several alveoli. Lymphatics are shown to be up to several alveoli away, i.e., hundreds of µms.
Wikipedia, https://commons.wikimedia.org/wiki/File:Lung_structure_normal.jpg, accessed October 19, 2022. (b) A two-dimensional model of a septal tract with capillary, interstitium, and alveolar compartments. See text for definitions.
Fig 1b is our two-dimensional model of a septal tract with three compartments: capillary, interstitium and alveolus. The capillary domain is 0 ≤ x ≤ L, -b ≤ y ≤ b while the interstitium domain is 0 ≤ x ≤ L, -d ≤ y’ ≤ d. Blood flow is driven by pressure differences between the upstream arterial, p(x=0) = pa, and downstream venous, p(x=L) = pv. The blood has pressure, p, and velocity components u,v in the x,y directions, respectively. It also has osmotic pressure, π, and viscosity, μ. The interstitial fluid has pressure, pi, velocity components uI, vi in the x and y’ directions, respectively. The end pressures are piB at x=0 and x=L. It also has osmotic pressure, πi, viscosity μi, and Darcy permeability, K. The capillary membrane has hydraulic conductivity, kc, with reflection coefficient, σc. The alveolar epithelial membrane has hydraulic conductivity, kA, with reflection coefficient, σA, and also has an active reabsorption velocity vab [16,17]. The alveolar liquid pressure is pAL and osmotic pressure is πAL, while the alveolar gas pressure is pAG. The surface tension between the alveolar gas and liquid is σ. Red arrows indicate interstitial end outflows at x=0 and x=L, which are available to the lymphatics. The lower half of the capillary and the lower interstitium strip and alveoli will be the mirror image of the upper half, so there is symmetry of the entire system with respect to the capillary centerline, y=0. An example of a spherical alveolus is shown in Fig 1b (right) with radius, R.
For prescribed values of the input parameters listed above and also in Table 1 with references, the pressure and velocity fields are calculated for the capillary, p(x,y), u(x,y), v(x,y) and for the interstitium, pi(x,y’), ui(x,y’), vi(x,y’).). The system is solved using Fourier series, see Tables A and B in S1 Appendix. From those solutions we characterize the underlying fluid mechanics of pulmonary edema and its clearance.
Results
The definitions of calculated flows are shown in Fig 2a which is a sketch for many of our general results. Let Qc be the two-dimensional volumetric flow rate across η = -1, the capillary membrane, i.e., . Let QA be the volumetric flow rate across at η = 1, the alveolar membrane, i.e.,
. When QA > 0 we have net alveolar edema and when QA < 0 we have net alveolar clearance. At x=0 (X=0) there are end-exit flows which are available to the lymphatics, Qc0 from the capillary and QA0 from the alveolus. In Fig 2b those contributions are separated by a yellow bounding streamline which intersects the x=0 boundary at
. That makes
and
. Both have negative values because ui < 0 at x=0. Their sum is the two-dimensional outflow from the interstitium toward the lymphatics at x=0. At x=L (X=1), the end-exit flows consist of Qc1 and QA1 from the capillary and alveolus, respectively, and there is a yellow bounding streamline in Fig 2b that intersects the X=1 boundary at
. Then
and
, where both have positive values. Their sum is the two-dimensional outflow from the interstitium toward the lymphatics at x=L. Let the total contribution from the alveolus to the lymphatics be QAL = |QA0| + |QA1| and from the capillary to the lymphatics be QcL = |Qc0| + |Qc1|. The model prediction that lymphatic flow has two competing, simultaneous sources is not a prevalent concept in lung physiology. The system was checked for the net difference in membrane crossflows equaling the lymphatic outflows, i.e.,
.
Note that the horizontal axis is compressed for 0.1 ≤ X ≤ 0.9 and circumscribed with a blue rectangle. The bounding streamlines in yellow separate alveolar and capillary contributions to the end-exit flows at X=0 and X=1 which become available to lymphatics., (c) Flow calculations for Normal/Recovery including BASE, PEEP and zero absorption velocity, vab = 0. Note QAL = QA0 + QA1 and QcL = Qc0 + Qc1. See text for details.
Fig 2b (upper) shows a solution to the governing equations using the input parameter values of Table 1 which we call BASE. The flow pattern is characterized with streamlines, velocity vector field, and a color-coded pressure field. The axes are X=x/L and η=y’/d. The central region, 0.1 ≤ X ≤ 0.9, has quasi one-dimensional flow in these coordinates, so is compressed in X to allow better visualization of the expanded end regions, 0.0 ≤ X ≤ 0.1 and 0.9 ≤ X ≤ 1.0, where the flow is fully two-dimensional.
In the central region, flow is from the alveolus to the capillary, i.e., clearance. In the end regions the streamlines are curvilinear and the exiting flows at X=0 and X=1 have contributions from both the capillary and the alveolus, separated by the bounding yellow streamline. These outflows become available to the lymphatics. The color-coded pressure field, pi(X,η), has a maximum of and decreases gradually for increasing X along with the capillary pressure which is transmitted through the capillary Starling equation. There are relatively steep X-gradients of pi in the end regions due to the proximity of the fixed end pressure, piB = -7.35 mmHg which come from subpleural measurements [18,19]. However, the central region pressure distribution has an η-dependence which is too small to reveal a color change. Nevertheless, it contributes to a dominant η-gradient of pi since the denominator distance scale is very small, 2d = 0.8 μm. This accounts for the direct crossflow, vi, in the central region from one membrane to the other.
For Fig 2b (upper) we calculate QA, QAL, Qc, and QcL, all shown in Fig 2c BASE. The percent of QA that exits the ends is, i.e., the alveolar-lymphatic clearance. It calculates to 9.9%, while the rest, 90.1%, is the alveolar-capillary clearance percent, i.e., directly across the interstitium in the central region. We observe that the flow is bidirectional at the capillary membrane, negative in the central region, but positive in the end regions. Setting vab = 0 results in similar flow patterns to Fig 2b (upper), but shifts the bounding end-exit streamlines upward, reducing QAL from -0.33 to -0.3 μm2/s. This is a new effect not previously associated with active reabsorption, that vab increases alveolar-lymphatic clearance. Second, in the central region the effect of vab is along the streamlines. For vab = 0 we calculate QA = -2.86 μm2/s which is 0.48 μm2/s less than the BASE value of QA = -3.34 μm2/s. This is due to the reabsorption volume flow rate contribution -vab × L = -10-3 μm/s × 500 μm = -0.5 μm2/s. The absorption velocity is essentially subtracted directly in the central region, which is the traditional understanding of reabsorption.
In Fig 2b (lower) the flow calculations for BASE with pAG = 15 cmH2O PEEP (Positive End Expiratory Pressure) are shown. PEEP is applied during acute CPE and ARDS, but continues on through recovery. The overall alveolar clearance flow is QA = -5.97 μm2/s, nearly double that of BASE, with -0.49 μm2/s exiting through the lymphatics. The bounding streamlines shift further toward the capillary compared to Fig 2b (upper) and the alveolar-lymphatic clearance percent computes to 8.2%.
Moving on to pulmonary edema, Fig 3a (upper) shows the results for CPE where BASE parameters are used, but with elevated blood pressure, pa = 28 mmHg, pv = 25 mmHg. Again, the central region, 0.1 ≤ X ≤ 0.9 is compressed. The overall flow is pulmonary edema with QA = 1.02 μm2/s as shown in Fig 3c. However, the flow across the capillary membrane is Qc = 5.01 μm2/s with QcL = 3.90 μm2/s, so 77.9% of the cross-capillary flow exits through the ends to the lymphatics. This is a protective function that diverts capillary fluid away from the alveolus. The maximum interstitial pressure is pi = +15mmHg. Again, we observe that the flow is bidirectional, but this time at the alveolar membrane, positive in the central region but negative in the end regions. Fig 3a (lower) is CPE with pAG = 15 cmH2O PEEP and the flow is reversed to be clearance with QA = -1.61 μm2/s and QAL = -0.46 μm2/s, ~29% alveolar-lymphatic clearance. This effect of PEEP on QA is much smaller, ~ 1/4th, than that seen in Fig 2c for the Normal/Recovery BASE parameter set. This is primarily due to the pressures opposing PEEP clearance, p and pi. For Fig 2b (lower) they are in a normal range, but for Fig 3a (lower) they are significantly elevated.
Note that the horizontal axis is compressed for 0.1 ≤ X ≤ 0.9 and circumscribed with a blue rectangle. The bounding streamlines in yellow separate alveolar and capillary contributions to the end-exit flows at X=0 and X=1 which become available to lymphatics. (c) flow calculations for (a), (d) flow calculations for (b), Note QAL = QA0 + QA1 and QcL = Qc0 + Qc1. See text for details.
Fig 3b (upper) represents results for ARDS which we model as BASE but with increased surface tension due to surfactant interference, σ = 40 dyn/cm, and increased osmotic pressure due to proteinaceous inflammation materials, πAL = 10mmHg. The hydraulic conductivities are increased by a factor of ten due to enhanced leakiness from inflammation: kA = 5×10-7 cm·mmHg-1·s-1 and kc = 10-5 cm·mmHg-1·s-1. The central region shows flow from the capillary to the alveolus, i.e., pulmonary edema, in the face of normal capillary, p, and interstitial, pi, pressures. The flow rates are Qc = 4.66 μm2/s and QA = 3.00 μm2/s, see Fig 3d. Fig 3b (lower) has pAG = 15 cmH2O PEEP and changes the flows to clearance with QA = -23.2 μm2/s and Qc = -21.2 μm2/s. This is a very strong effect of PEEP and reflects the 10-fold increase in both kc and kA which control membrane crossflow in either direction, i.e., edema or clearance. In addition, the pressures opposing clearance for ARDS, pi and p, are in normal ranges, compared to PEEP used in CPE where pi and p are significantly elevated. Comparing Fig 3c to Fig 2c, QA is nearly 15 times smaller with PEEP in CPE vs PEEP in ARDS, while Qc has switched signs and is approximately 10 times smaller.
Because the capillary blood pressure is dropping in the X direction, it is possible to have edema upstream with clearance downstream. Fig 4a is CPE, but with a lower value of PEEP at pAG = 7 cmH2O. As we have seen before, the end region bounding streamlines separate the positive capillary crossflow which exits to the lymphatics and the negative epithelial crossflow which also exit to the lymphatics. Then there is a recirculation region in the central section with a third bounding streamline. Inside that streamline flow enters and exits the interstitium which is protective. If we also then increase K by a factor of 10, labeled as 10K, Fig 4b shows the closed streamline opens downstream since X-direction velocities increase.
(a) CPE with pAG = 7 cmH2O PEEP, (b) CPE with 7 cmH2O PEEP and 10K..
Velocities in the X-direction, ui, are small in the central region but become relatively large in the end regions as the pressure X-gradients increase. Fig 5a compares the horizontal velocities ui(η) at X = 0.0,0.02,0.05,0.95,0.98,1.0, for BASE. The capillary pressure is highest at the arterial end, X=0, where p(X=0) = pa, Consequently, it drives the fastest end-exit velocity out of the interstitium there. The average ui ~ -0.58 μm/s, while at the other exit, X=1, the average ui ~ 0.25 μm/s. The other values of X shown in Fig 5a are very close to the respective exits. The average at X=0.5 is ui = 5.8×10-3 μm/s which is 100 times smaller than at X=0 and similar to vi at X=0.5. Note the very thin boundary layers at the alveolar and capillary membranes, η=±1, to match the no-slip conditions. This is an advantage of the Brinkman model vs the Darcy model which cannot satisfy no-slip. Fig 5b for CPE shows all of the velocities in the end regions increasing significantly by factors of ~ 5–10.
for (a) BASE (b) CPE. (c) ui (η=0) vs X for BASE, CPE, CPE + 10K, CPE + 100K, ARDS. (d) wall shear stress τw for the alveolar membrane for BASE, CPE, CPE with10K, CPE 100K, and ARDS.
Fig 5c shows the centerline velocity ui (η=0) vs X for BASE, CPE, CPE with 10K (ten times BASE K), CPE with 100K (100 times BASE K), and ARDS. Note that BASE and ARDS overlap because they have similar, normal pressure distributions, pi. Increasing K has a significant effect on increasing the velocities and extending the end regions while shrinking the central regions, as shown in Fig 6a and 6b for 10K and 100K. The wall shear stress on the alveolar epithelial and capillary membranes are very similar, so in Fig 5d we plot only the epithelial membrane wall shear, τw (X) corresponding to Fig 5c. The values range from τw ~ 0.02 dyn/cm2 in the central region to 12 dyn/cm2 at the ends for CPE with 100K.
(a)10K and (b) 100K.
Discussion
Our model solves the pressure, velocity, and shear stress field for interstitial flow coupled to the capillary and alveolar compartments through respective Starling equations. The calculations are for an instantaneous state and do not follow physiological changes in time such as breathing motions, interstitial swelling and fluid shifts. All parameters are treated independently, so, for example, values of b, d, and K do not respond to the pressure pi directly. The reabsorption of fluid across the alveolar epithelial membrane is modeled with a prescribed velocity -vab inserted into that Starling equation. We find that -vab has two effects: shifting streamlines toward the capillary in the end regions to garner more alveolar-lymphatic clearance; and, directly subtracting from crossflows in the central region to increase alveolar-capillary clearance. For the Normal/Recovery BASE state ~ 90% of edema clearance from the alveolus was directly across the interstitial layer to the capillary. The Brinkman model for the interstitium lets us calculate wall shear stresses on the membranes, and we find their range of values are known to be physiologically stimulating to both endothelial and alveolar epithelial cells in other contexts, but from the interstitial side.
With regard to the wall shear, τw, calculations in Fig 4d it has been shown that fluid shear stress on alveolar type II cells in a microfluidic device can stimulate surfactant production, as studied in a range of 4–20 dyn/cm2 [20]. Capillary endothelial cells have been studied extensively for their response to shear stress from the blood flow [21,22]. In either case, shear stress gradients can also stimulate biological responses, which are significant in the end regions of Fig 4d. For both membranes, alveolar epithelium and capillary endothelium, our model is the first to estimate fluid shear stresses from the interstitial side.
For many applications the central region flow is essentially one-dimensional across the interstitium, with 3 resistances in series: the capillary membrane, the interstitial matrix, and the alveolar membrane. For convenience call, ,
,
, and
. Then the two Starling’s laws at the capillary,
, and alveolar
membranes where
and
. Using similar notation, the porous media flow across the interstitial layer is essentially Darcy since there are no tangential boundaries. Let the vertical velocity in the layer be
where
. Setting viA = vic and vic = vi we can solve for pic and piA. We recognize that ki = 1.28×10-4 cm·mmHg-1·s-1 is much larger than kA = 5×10-8 cm·mmHg-1·s-1 and kc = 1×10-6 cm·mmHg-1·s-1. The resistances to flow are ordered by the size of the reciprocals, 1/kA>> 1/kc>> 1/ki. Clearly 1/kA dominates and we can take the limit kA/ki → 0, kc/ki → 0 to simplify the result as
The alveolar contributions are all multiplied by (kA/kc) = 0.05 for our base state, so the capillary contributions, , dominate Eq. (1). Since p decreases essentially linearly in the central region, let X=0.5 where p ~ (pA + pv)/2. For BASE parameters Eq. (1) yields pi = -3.7 mmHg (-3.2 mmHg with 15 cmH2O PEEP), CPE 14.4 mmHg (14.9 mmHg with 15 cmH2O PEEP), and ARDS -4.4 mmHg (-3.9 mmHg with 15 cmH2O PEEP) which equal the full solution values. For our ARDS model we multiplied both kA and kc by 10, so the ratio kA/kc did not change and interstitial pressure remained normal as shown in Fig 3b.
To solve for the critical capillary blood pressure, pcrit, which leads to edema, we substitute pic from Eq. (1) into vic and set vic = 0. The result is
where we have substituted for pAL from the Law of Laplace. Edema flow occurs when p > pcrit, and alveolar-capillary clearance when p < pcrit. Major clinical methods to increase pcrit can be seen in Eq. (2) to include increasing pAG, π and vab or decreasing σ and πAL. In many modeling approaches, the reflection coefficients are taken to be equal, σc = σA, as we do, so πi drops out.
Surface tension, σ, is elevated when there is a surfactant deficiency, as occurs in premature neonates [23–25] or ARDS where surfactant function is hampered. These neonates develop pulmonary edema which is reversed with surfactant therapy, indicating that their alveolar capillary blood pressure is above pcrit with high surface tension and then below it after treatment [26]. One of the major pulmonary targets of COVID-19 are the alveolar type II cells [27] reducing production. The effect of reabsorption velocity, vab, is to increase pcrit as one might expect. It appears as vab/kA = 2 mmHg in BASE. It is reassuring that our parameter choices from the wide literature lead to this reasonable result for reabsorption. Interestingly, kA tends to increase in ARDS, as membranes become leakier due to inflammation, thereby reducing the protective effect of vab, just when it is needed.
For our base state parameter set, BASE, Eq. (2) yields pcrit = 21.4mmHg,19.4 mmHg for vab=0. These values are consistent with the clinical setting where (PCWP) > 18 mmHg is considered diagnostic for CPE [10]. This is why our CPE examples led to pulmonary edema. The value drops to pcrit = 6.2 mmHg for ARDS causing edema for normal vascular pressures. Adding PEEP of pAG = 15 cmH2O to ARDS increased pcrit = 17.2 mmHg, allowing clearance. PEEP of pAG = 15 cmH2O applied to CPE led to clearance in the central region and contributions to the end-exit flows from both capillary and alveolus. However, PEEP of pAG = 7 cmH2O applied to that CPE led to upstream edema but downstream clearance. These comparisons constitute model validation for its one-dimensional predictions. Validation of two-dimensional predictions hinges on measurements of lymphatic outflow from the lung. Here are three examples.
In [28] left atrial pressure (LAP) was increased stepwise in unanesthetized sheep, while measuring the lung efferent lymph duct output. They found lymphatic flow increased approximately linearly with LAP. We have calculated our total lymphatic output, (QAL + QcL) vs the average capillary pressure, (pa + pv)/2, for the pressure pairs (pa,pv) = (9,6), (12,9), (15,12), (18,15), (20,17), (21,18), (24,21), (28,25) mmHg. The results show an excellent linear curve fit (QAL + QcL) = 0.18(pa + pv)/2 - 0.64, R² = 0.99, see Fig 7. They [28] also determined that lymph protein concentration decreased approximately linearly with LAP from sieving of capillary fluid. We found linearly increasing QcL = 0.190(pa + pv)/2 - 1.16, R² = 0.99 but decreasing QAL = -0.016(pa + pv)/2 + 0.52, R² = 0.84. An increasing share of the end-exit flow comes from the capillary, which dilutes the protein level in the lymphatic fluid from washout.
+pv)/2.
Sheep studies following acute hydrostatic pulmonary edema [29] were studied for overall clearance, determined from decreasing extravascular lung water (EVLW), while measuring the lymphatic contribution. Lymphatics contribute between 8.8 to 14.6% of total clearance. Using our BASE model we found the alveolar-lymphatic clearance percent was 9.9% while total lymphatic flow was . This percentage reduces to 12.5% by increasing L to 800µm since |QA| increases from the longer surface while
remains essentially the same. Other investigators have found alveolar-lymph clearance is 4% [30] and 18% [31] of the total as discussed in [32].
In dog experiments [33], was increased by treatment with inhaled aerosol of dioctyl sodium sulfosuccinate. LAPs were step-wise increased to cause edema. Controls with normal
showed lymphatic flow increases over baseline for elevated LAP. However, treated dogs exhibited much larger lymphatic flow rates for similar LAP, since the pressures were further above the lowered. For example, increasing the surface tension by a factor of 10, σ = 40 dyn/cm, leads to pcrit = 16 mmHg, so more lung units are susceptible to edema. Our model fits these three sets of experimental results providing two-dimensional validation.
Previous experimental studies of the general topic [34–37] involve pressure measurements in subpleural interstitium to include interalveolar junctions and perivascular adventitia of 50μm venules. This is a significantly different mechanical environment from what we are studying: alveolar septal fluid mechanics. A more global approach [34] involves pressures measured by micropuncture both in the subpleural alveolar interstitium and the hilum. The investigators find a pressure difference tending to cause flow to the hilum, a proposed mechanism of clearance from the alveoli. However, the intervening alveolar septa have pressures, pi, which we calculate to be higher than both the hilum and subpleural pressures, so any flow from the subpleura to the hilum would need to circumnavigate that pressure barrier.
Traditional lung physiology [38] describes the alveolar fluid balance through the capillary Starling equation alone, with p = 7mmHg, pi = -8 mmHg, π = -28 mmHg, πI = -14 mmHg and σA = σc = 1. The constant value pi is an input, taken from subpleural measurements similar to our piB of -7.35 mmHg [18,19]. It does not agree with our calculated output values in the central region which are more positive and not constant. The sum [38] is +1 mmHg causing flow across the capillary membrane into the interstitium. It is presented that lymphatics in the interstitium pump out the excess fluid, but may not keep up leading to edema. This explanation of pulmonary edema forms the teaching basis to 10 million physicians and 20 million nurses world-wide. In reality, however, lymphatics are up to hundreds of away from alveoli [13], i.e., too far to suck interstitial fluid over that distance. The mechanism presented in our model, that the capillary pressure is transmitted to the interstitium over a finite membrane length, drives interstitial fluid toward the lymphatics. It resolves a puzzle since 1896 [11,39] as to how alveolar lymphatics function from so far away. The model also can explain the relative paucity of lymphatics in the alveoli, since alveolar-capillary clearance carries a majority of the load compared to alveolar-lymphatic clearance.
The model not only provides a novel understanding of pulmonary interstitial clearance in both normal and diseased states, but also provides a simple equation, Eq. (2), with variables that can be readily manipulated by the clinician at the bedside to improve clearance of the pulmonary interstitium. For example, pulmonary venous pressure, pv, in both CPE and non-CPE may be reduced with diuretics while capillary oncotic pressure, π, may be increased with intravenous albumin in proteinemic patients. Glucocorticoids reduce elevated kc, kA in select patients with ARDS. Notably, the application of PEEP can be individualized in both disease states to improve the direction of fluid-flow from alveoli to capillary. In the wake of the COVID-19 pandemic, there have been numerous publications devoted to the personalization of PEEP in ARDS to optimize alveolar recruitment and limit alveolar overdistension using bedside tools such as esophageal manometry (Pes) and electrical impedance tomography (EIT) [40,41]. The application and titration of PEEP is often thought of as a method for alveolar recruitment to improve tidal volume distribution, lung mechanics, and pulmonary gas exchange. In “non-recruitable” patients, PEEP may over-distend open alveoli resulting in volutrauma and ventilator-induced lung injury. However, PEEP is not currently perceived as a method to improve clearance of alveolar and interstitial edema. The above model would allow the bedside clinician to calculate the PEEP required to lower pcrit and improve interstitial edema clearance, which could play an integral role in PEEP-personalization in both CPE and non-CPE alike. Further studies and animal models are needed to integrate this novel model into clinical applications.
Methods
Capillary blood flow is modeled using lubrication theory leading to a locally parabolic profile. In our previous model [11] we used Darcy’s law for the interstitium. However, here we use the Brinkman model, which allows us to calculate shear stresses. Conservation of mass for the interstitium yields Laplace’s equation for pi,
. The end pressures are set to a constant pi(x=0)=pi(x=L)=piB. Crossflow at the permeable capillary membrane is given by the Starling equation [42]
. We also need to match the crossflow velocities there,
The alveolar membrane boundary condition is also modelled using a Starling equation, however this membrane has active transport processes for water and salt [16,17] which can help to resolve pulmonary edema over time. We propose a unique modification by subtracting an absorption velocity term, vab > 0, as follows
.
We can estimate vab from rat data on the overall rate of volume absorption [43] given in as under normal conditions and can be ~ 40% higher for Congestive Heart Failure. Measurements of rat alveolar surface area [44] are in the range of 2,000 cm2 at an inflation of 24% TLC. Dividing the flow rate by the surface area yields
. This value can be an underestimate, since not all of the available alveolar surface area likely participates in reabsorption. However, it can also be an overestimate, since passive processes from the hydraulic and osmotic pressures also lead to clearance to capillary and lymphatics. We will choose vab = 10-3 μm/s. There are a number of clinical situations which will reduce vab [45] including hypoxia [46], ARDS [47], and congestive heart failure [48].
We use the following base parameter values (BASE): b = 3 μm, d = 0.4 μm, K = 10-13 cm2, L = 500 μm, μ = 0.02 poise, μi = 0.013 poise, pa = 9 mmHg, pv = 6 mmHg, pAG = 0 mmHg, σ = 4dyn/cm, piB = -7.35 mmHg, π = 25 mmHg, πAL = 0 mmHg, πI = 10.15 mmHg, kA = 5x10-8 cm·mmHg-1·s-1, kc = 1x10-6 cm·mmHg-1·s-1, vab = 10-3 μm/s, R=0.01 cm, σA = σc = 0.8. Detailed discussion of these choices from extensive references are found in [11] and Table 1. Using the Law of Laplace, we calculate the alveolar liquid pressure, pAL in mmHg from the alveolar gas pressure, pAG, in cmH2O and the surface tension, σ, in dyn/cm, as using the conversion factors 1 mmHg = 1.36 cmH2O and 1 mmHg = 1333 dyn/cm2.
Supporting information
S1 Appendix. Detailed solution method.
Table A. Dimensionless parameters. Table B. Dimensional and dimensionless variables.
https://doi.org/10.1371/journal.pcbi.1012917.s001
(DOCX)
References
- 1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6–245.
- 2. Amado-Rodríguez L, Rodríguez-Garcia R, Bellani G, Pham T, Fan E, Madotto F, et al. Mechanical ventilation in patients with cardiogenic pulmonary edema: a sub-analysis of the LUNG SAFE study. J Intensive Care. 2022;10(1):55. pmid:36567347
- 3. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1334–49. pmid:10793167
- 4. Ware LB, Matthay MA. Clinical practice. Acute pulmonary edema. N Engl J Med. 2005;353(26):2788–96. pmid:16382065
- 5. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353(16):1685–93. pmid:16236739
- 6. Villar J, Blanco J, Kacmarek RM. Current incidence and outcome of the acute respiratory distress syndrome. Curr Opin Crit Care. 2016;22(1):1–6. pmid:26645551
- 7. Gibson PG, Qin L, Puah SH. COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust. 2020;213(2):54-56.e1. pmid:32572965
- 8. Ackermann M, Verleden S, Kuehnel M, Haverich A, Welte T, Laenger F. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–8.
- 9. Schaller T, Hirschbühl K, Burkhardt K, Braun G, Trepel M, Märkl B. Postmortem examination of patients with COVID-19. JAMA. 2020;323(24):2518–20.
- 10.
Sidebotham D, McKee A, Gillham M, Levy J. Cardiothoracic Critical Care: Elsevier Health Sciences; 2007.
- 11. Grotberg J, Romanò F. Computational pulmonary edema: A microvascular model of alveolar capillary and interstitial flow. APL Bioengineering. 2023;7(3):036101.
- 12.
Wikimedia Commons. Lung structure normal.jpg 2013 [
- 13. Weber E, Sozio F, Borghini A, Sestini P, Renzoni E. Pulmonary lymphatic vessel morphology: a review. Ann Anat. 2018;218:110–7. pmid:29679722
- 14. Vasilescu DM, Phillion AB, Kinose D, Verleden SE, Vanaudenaerde BM, Verleden GM, et al. Comprehensive stereological assessment of the human lung using multiresolution computed tomography. J Appl Physiol (1985). 2020;128(6):1604–16. pmid:32298211
- 15. Gehr P, Bachofen M, Weibel ER. The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir Physiol. 1978;32(2):121–40. pmid:644146
- 16. Matthay MA, Folkesson HG, Verkman AS. Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol. 1996;270(4 Pt 1):L487-503. pmid:8928808
- 17. Matthay MA, Flori HR, Conner ER, Ware LB. Alveolar epithelial fluid transport: basic mechanisms and clinical relevance. Proc Assoc Am Physicians. 1998;110(6):496–505. pmid:9824532
- 18. Miserocchi G, Negrini D, Passi A, De Luca G. Development of lung edema: interstitial fluid dynamics and molecular structure. News in Physiol Sci. 2001;16:66–71.
- 19. Miserocchi G, Negrini D, Del Fabbro M, Venturoli D. Pulmonary interstitial pressure in intact in situ lung: transition to interstitial edema. J Appl Physiol (1985). 1993;74(3):1171–7. pmid:8482655
- 20. Mahto SK, Tenenbaum-Katan J, Greenblum A, Rothen-Rutishauser B, Sznitman J. Microfluidic shear stress-regulated surfactant secretion in alveolar epithelial type II cells in vitro. Am J Physiol Lung Cell Mol Physiol. 2014;306(7):L672-83. pmid:24487389
- 21. Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med. 2009;6(1):16–26. pmid:19029993
- 22. Chistiakov DA, Orekhov AN, Bobryshev YV. Effects of shear stress on endothelial cells: go with the flow. Acta Physiol (Oxf). 2017;219(2):382–408. pmid:27246807
- 23. Tai C, Vaughan B, Florens M, Filoche M, Grotberg J. Liquid and drug delivery into a 3D lung tree. Am J Respir Crit Care Med. 2011;183:A2298.
- 24. Filoche M, Tai C-F, Grotberg JB. Three-dimensional model of surfactant replacement therapy. Proc Natl Acad Sci U S A. 2015;112(30):9287–92. pmid:26170310
- 25. Grotberg JB, Filoche M, Willson DF, Raghavendran K, Notter RH. Did reduced alveolar delivery of surfactant contribute to negative results in adults with acute respiratory distress syndrome?. Am J Respir Crit Care Med. 2017;195(4):538–40. pmid:28199167
- 26. Swischuk LE, Shetty BP, John SD. The lungs in immature infants: How important is surfactant therapy in preventing chronic lung problems?. Pediatr Radiol. 1996;26(8):508–11. pmid:8753660
- 27. Carcaterra M, Caruso C. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory. Med Hypotheses. 2021;146:110412.
- 28. Erdmann A, Vaughan T, Brigham K, Woolverton W, Staub N. Effect of increased vascular pressure on lung fluid balance in unanesthetized sheep. Circ Res. 1975;37(3):271–84.
- 29. Mackersie RC, Christensen J, Lewis FR. The role of pulmonary lymphatics in the clearance of hydrostatic pulmonary edema. J Surg Res. 1987;43(6):495–504. pmid:3695450
- 30. Effros RM, Parker JC. Pulmonary vascular heterogeneity and the Starling hypothesis. Microvasc Res. 2009;78(1):71–7. pmid:19332080
- 31. Pearse DB, Wagner EM, Sylvester JT. Edema clearance in isolated sheep lungs. J Appl Physiol (1985). 1993;74(1):126–32. pmid:8444682
- 32. Beretta E, Romanò F, Sancini G, Grotberg JB, Nieman GF, Miserocchi G. Pulmonary interstitial matrix and lung fluid balance from normal to the acutely injured lung. Front Physiol. 2021;12:781874. pmid:34987415
- 33. Bredenberg C, Nieman G, Paskanik A, Hart A. Microvascular membrane permeability in high surface tension pulmonary edema. J Appl Physiol. 1986;60(1):253–9.
- 34. Bhattacharya J, Gropper M, Staub N. Interstitial fluid pressure gradient measured by micropuncture in excised dog lung. J Appl Physiol Respir Environ Exerc Physioly. 1984;56(2):271–7.
- 35. Bhattacharya J, Gropper MA, Shepard JM. Lung expansion and the perialveolar interstitial pressure gradient. J Appl Physiol (1985). 1989;66(6):2600–5. pmid:2745322
- 36. Glucksberg MR, Bhattacharya J. Effect of vascular pressure on interstitial pressures in the isolated dog lung. J Appl Physiol (1985). 1993;75(1):268–72. pmid:8376272
- 37. Ford TR, Sachs JR, Grotberg JB, Glucksberg MR. Perialveolar interstitial resistance and compliance in the isolated rat lung. J Appl Physiol. 1991;70(6):2750–6.
- 38.
Hall JE, Guyton AC. Guyton and Hall Textbook of Medical Physiology. 12th ed. Philadelphia, PA: Saunders/Elsevier; 2011.
- 39.
Miller WS. The lymphatics of the lung. Dehli, India: Pranava Books; 1896.
- 40. Grotberg JC, Reynolds D, Kraft BD. Management of severe acute respiratory distress syndrome: a primer. Crit Care. 2023;27(1):289. pmid:37464381
- 41. Jimenez JV, Weirauch AJ, Culter CA, Choi PJ, Hyzy RC. Electrical impedance tomography in acute respiratory distress syndrome management. Crit Care Med. 2022;50(8):1210–23. pmid:35607967
- 42. Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol. 1896;19(4):312–26. pmid:16992325
- 43. Azzam ZS, Adir Y, Welch L, Chen J, Winaver J, Factor P, et al. Alveolar fluid reabsorption is increased in rats with compensated heart failure. Am J Physiol Lung Cell Mol Physiol. 2006;291(5):L1094-100. pmid:16815890
- 44. Tschumperlin DJ, Margulies SS. Alveolar epithelial surface area-volume relationship in isolated rat lungs. J Appl Physiol (1985). 1999;86(6):2026–33. pmid:10368370
- 45. Matthay MA. Resolution of pulmonary edema. Thirty years of progress. Am J Respir Crit Care Med. 2014;189(11):1301–8. pmid:24881936
- 46. Dada LA, Sznajder JI. Hypoxic inhibition of alveolar fluid reabsorption. Adv Exp Med Biol. 2007;618:159–68. pmid:18269195
- 47. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163(6):1376–83. pmid:11371404
- 48. Saldías FJ, Azzam ZS, Ridge KM, Yeldandi A, Rutschman DH, Schraufnagel D, et al. Alveolar fluid reabsorption is impaired by increased left atrial pressures in rats. Am J Physiol Lung Cell Mol Physiol. 2001;281(3):L591–7. pmid:11504685
- 49. Mühlfeld C, Weibel ER, Hahn U, Kummer W, Nyengaard JR, Ochs M. Is length an appropriate estimator to characterize pulmonary alveolar capillaries? A critical evaluation in the human lung. Anat Rec (Hoboken). 2010;293(7):1270–5. pmid:20583281
- 50. Weibel ER, Gomez DM. Architecture of the human lung. Use of quantitative methods establishes fundamental relations between size and number of lung structures. Science. 1962;137(3530):577–85. pmid:14005590
- 51. Crapo JD, Young SL, Fram EK, Pinkerton KE, Barry BE, Crapo RO. Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am Rev Respir Dis. 1983;128(2 Pt 2):S42-6. pmid:6881707
- 52. Mercer RR, Russell ML, Crapo JD. Alveolar septal structure in different species. J Appl Physiol (1985). 1994;77(3):1060–6. pmid:7836104
- 53. Zakaria el-R, Lofthouse J, Flessner MF. In vivo hydraulic conductivity of muscle: effects of hydrostatic pressure. Am J Physiol. 1997;273(6):H2774-82. pmid:9435614
- 54. Vargas CB, Vargas FF, Pribyl JG, Blackshear PL. Hydraulic conductivity of the endothelial and outer layers of the rabbit aorta. Am J Physiol. 1979;236(1):H53-60. pmid:434174
- 55. Swabb E, Wei J, Gullino P. Diffusion and convection in normal and neoplastic tissues. Cancer Research. 1974;34(10):2814–22.
- 56. Guyton AC, Scheel K, Murphree D. Interstitial fluid pressure. 3. Its effect on resistance to tissue fluid mobility. Circ Res. 1966;19(2):412–9. pmid:5914853
- 57. Pishko GL, Astary GW, Mareci TH, Sarntinoranont M. Sensitivity analysis of an image-based solid tumor computational model with heterogeneous vasculature and porosity. Ann Biomed Eng. 2011;39(9):2360–73. pmid:21751070
- 58. Schaeffer JD, Kim KJ, Crandall ED. Effects of cell swelling on fluid flow across alveolar epithelium. J Appl Physiol Respir Environ Exerc Physiol. 1984;56(1):72–7. pmid:6607246
- 59. Crandall E, Kim K. Transport of water and solutes across bullfrog alveolar epithelium. J Appl Physiol. 1981;50(6):1263–71.
- 60. Curry FE, Frøkjaer-Jensen J. Water flow across the walls of single muscle capillaries in the frog, Rana pipiens. J Physiol. 1984;350:293–307. pmid:6611400
- 61. Michel CC. Filtration coefficients and osmotic reflexion coefficients of the walls of single frog mesenteric capillaries. J Physiol. 1980;309:341–55. pmid:6973022
- 62. Kim M, Harris NR, Tarbell JM. Regulation of capillary hydraulic conductivity in response to an acute change in shear. Am J Physiol Heart Circ Physiol. 2005;289(5):H2126-35. pmid:15994851
- 63. Rippe B, Kamiya A, Folkow B. Simultaneous measurements of capillary diffusion and filtration exchange during shifts in filtration-absorption and at graded alterations in the capillary permeability surface area products (PS). Acta Physiol Scand. 1978;104(3):318–36. pmid:102112
- 64. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 1987;6(4):559–93. pmid:3327633
- 65. Staub N, Schultz E. Pulmonary capillary length in dogs, cat and rabbit. Respiratory Physiology. 1968;5(3):371–8.
- 66. Miyamoto Y, Moll W. Measurements of dimensions and pathway of red cells in rapidly frozen lungs in situ. Respir Physiol. 1971;12(2):141–56.
- 67. Godbey P, Graham J, Presson R, Wagner W, Lloyd T. Effect of capillary pressure and lung distension on capillary recruitment. J Appl Physiol. 1995;79(4):1142–7.
- 68. Yen RT, Fung YC. Model experiments on apparent blood viscosity and hematocrit in pulmonary alveoli. J Appl Physiol. 1973;35(4):510–7. pmid:4743010
- 69. Zurovsky Y, Mitchell G, Hattingh J. Composition and viscosity of interstitial fluid of rabbits. Exp Physiol. 1995;80(2):203–7. pmid:7786512
- 70. Hakim TS, Gilbert E, Camporesi E. Positive end-expiratory pressure increases capillary pressure relative to wedge pressure in the closed and open chest. J Crit Care. 1993;8(2):80–6. pmid:8343866
- 71. Negrini D, Passi A, Bertin K, Bosi F, Wiig H. Isolation of pulmonary interstitial fluid in rabbits by a modified wick technique. Am J Physiol Lung Cell Mol Physiol. 2001;280(5):L1057-65. pmid:11290531
- 72. Ochs M, Nyengaard JR, Jung A, Knudsen L, Voigt M, Wahlers T, et al. The number of alveoli in the human lung. Am J Respir Crit Care Med. 2004;169(1):120–4. pmid:14512270
- 73. Valberg P, Brain J. Lung surface tension and air space dimensions from multiple pressure-volume curves. J Appl Physiol Respir Environ Exerc Physiol. 1977;43(4):730–8.
- 74. Parker JC, Guyton AC, Taylor AE. Pulmonary interstitial and capillary pressures estimated from intra-alveolar fluid pressures. J Appl Physiol Respir Environ Exerc Physiol. 1978;44(2):267–76. pmid:632166
- 75. Parker JC. Hydraulic conductance of lung endothelial phenotypes and Starling safety factors against edema. Am J Physiol Lung Cell Mol Physiol. 2007;292(2):L378-80. pmid:17041015